2,540
Views
34
CrossRef citations to date
0
Altmetric
Review Article

The impact of respiratory viruses on lung health after preterm birth

, , &
Article: 1487214 | Received 05 Dec 2017, Accepted 03 Jun 2018, Published online: 01 Aug 2018

References

  • World Health Organization. Born too soon: the global action report on preterm birth. 2012.
  • Greenough A. Long-term pulmonary outcome in the preterm infant. Neonatology. 2008;93(4):324–11.
  • de Mello RR, Dutra MV, Lopes JM. Respiratory morbidity in the first year of life of preterm infants dis- charged from a neonatal intensive care unit. J Pediatr (Rio J). 2004; 80(6):503–510.
  • Been JV, Lugtenberg MJ, Smets E, et al. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. PLoS Med. 2014;11(1):e1001596.
  • Lamarche-Vadel A, Blondel B, Truffer P, et al. Rehospitalization in infants younger than 29 weeks’ gestation in the EPIPAGE cohort. Acta Paediatrica (Oslo, Norway: 1992). 2004;93(10):1340–1345.
  • Miller JE, Hammond GC, Strunk T, et al. Association of gestational age and growth measures at birth with infection-related admissions to hospital throughout childhood: a population-based, data-linkage study from Western Australia. Lancet Infect Dis. 2016;16:952–961.
  • Smith VC, Zupancic JA, McCormick MC, et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr. 2004;144 (6):799–803.
  • Northway WH, Jr., Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline membrane disease. Bronchopulmonary Dysplasia. N Engl J Med. 1967;276(7):357–368.
  • Smith VC, Zupancic JA, McCormick MC, et al. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr. 2005;146(4):469–473.
  • Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29(7): 710–717.
  • Jobe AH, E. Bancalari. Bronchopulmonary dysplasia. Am J Respir Crit Care, 2001;163(7):1723–1729.
  • Coalson, J.J. Pathology of new bronchopulmonary dysplasia. Seminars in Neonatology. Elsevier; 2003.
  • Smith LJ, McKay KO, van Asperen PP, et al. Normal development of the lung and premature birth. Paediatr Respir Rev. 2010;11(3):135–142.
  • Han S, Mallampalli RK. The role of surfactant in lung disease and host defense against pulmonary infections. Ann Am Thorac Soc. 2015;12(5):765–774.
  • Hillaire MLB, Haagsman HP, Osterhaus ADME, et al. Pulmonary surfactant protein D in first-line innate defence against Influenza A virus infections. J Innate Immun. 2013;5(3):197–208.
  • Hartmann F, Fiori HH, Garcia PCR, et al. Surfactant deficiency in infants with severe acute viral bronchiolitis. J Pediatr. 2014;164(6):1432–1435.
  • Marodi L. Innate cellular immune responses in newborns. Clin Immunol (Orlando, Fla). 2006;118(2–3):137–144.
  • Melville JM, Moss T. The immune consequences of preterm birth. Front Neurosci. 2013;7(79):1–9.
  • Garcia C, Soriano-Fallas A, Lozano J, et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J. 2012;31(1):86–89.
  • Strunk T, Currie A, Richmond P, et al. Innate immunity in human newborn infants: prematurity means more than immaturity. J Maternal-Fetal Neonatal Med: off J Eur Assoc Perinatal Med, Fed Asia Oceania Perinatal Soc, Inter Soc Perinatal Obstet. 2011;24(1):25–31.
  • Tissières P, Ochoda A, Dunn-Siegrist I, et al. Innate immune deficiency of extremely premature neonates can be reversed by Interferon-γ. PLoS One. 2012;7(3): e32863.
  • Pancham K, Perez GF, Huseni S, et al. Premature infants have impaired airway antiviral IFNgamma responses to human metapneumovirus compared to respiratory syncytial virus. Pediatr Res. 2015; 78 4):389–394.
  • Van den Berg JP, Westerbeek EAM, Frm VDK, et al. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev. 2011;87(2):67–72.
  • Marr N, Wang TI, Kam SH, et al. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. J Immunol (Baltimore, Md: 1950). 2014;192(3):948–957.
  • Marchant EA, Kan B, Sharma AA, et al. Attenuated innate immune defenses in very premature neonates during the neonatal period. Pediatr Res. 2015;78 (5):492–497.
  • Kallapur SG, Jobe AH, Ball MK, et al. Pulmonary and systemic endotoxin tolerance in preterm fetal sheep exposed to chorioamnionitis. J Immunol;2007;179 (12): 8491–8499.
  • Melville JM, Bischof RJ, Meeusen EN, et al. Changes in fetal thymic immune cell populations in a sheep model of intrauterine inflammation. Reprod Sci 2012;19(7):740–747.
  • Chabra S, Cotttrill C, Rayens MK, et al. Lymphocyte subsets in cord blood of preterm infants: effect of antenatal steroids. Biol Neonate. 1998;74(3):200–207.
  • Korppi M, Piippo-Savolainen E, Korhonen K, et al. Respiratory morbidity 20 years after RSV infection in infancy. Pediatr Pulmonol. 2004;38(2):155–160.
  • Zomer-Kooijker K, van der Ent CK, Ermers MJ, et al. Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection. PLoS One. 2014;9(1):e87162.
  • Kouzouna A, Gilchrist F, Ball V, et al. A systematic review of early life factors which adversely affect subsequent lung function. Paediatr Respir Rev. 2016;20:67–75.
  • Edwards MO, Kotecha SJ, Lowe J, et al. Management of Prematurity-Associated Wheeze and Its Association with Atopy. PLoS One, 2016. 11(5): e0155695.
  • Civardi E, Tzialla C, Baldanti F, et al. Viral outbreaks in neonatal intensive care units: what we do not know. Am J Infect Control. 2013;41(10):854–856.
  • Gastmeier P, Loui A, Stamm-Balderjahn S, et al. Outbreaks in neonatal intensive care units - they are not like others. Am J Infect Control. 2007;35(3):172–176.
  • Kidszun A, Hansmann A, Winter J, et al. Detection of respiratory viral infections in neonates treated for suspicion of nosocomial bacterial sepsis: a feasibility study. Pediatr Infect Dis J. 2014;33(1):102–104.
  • Gonzalez-Carrasco E, Calvo C, Garcia-Garcia ML, et al. [Viral respiratory tract infections in the Neonatal Intensive Care Unit]. Anales De Pediatria (Barcelona, Spain: 2003). 2015;82(4):242–246.
  • Bennett NJ, Tabarani CM, Bartholoma NM, et al. Unrecognized viral respiratory tract infections in premature infants during their birth hospitalization: a prospective surveillance study in two neonatal intensive care units. J Pediatr. 2012;161(5):814–8. e3.
  • Pramana IA, Latzin P, Schlapbach LJ, et al. Respiratory symptoms in preterm infants: burden of disease in the first year of life. Eur J Med Res. 2011;16(5):223–230.
  • Figueras-Aloy J, Manzoni P, Paes B, et al. Defining the risk and associated morbidity and mortality of severe respiratory syncytial virus infection among preterm infants without chronic lung disease or congenital heart disease. Infect Dis Ther. 2016;1–36.
  • Underwood M, Danielsen B, Gilbert W. Cost, causes and rates of rehospitalization of preterm infants. J Perinatology. 2007;27(10):614–619.
  • Pérez-Yarza EG, Moreno-Galdó A, Ramilo O, et al. Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life. Pediatr Allergy Immunol. 2015;26(8):797–804.
  • Olabarrieta I, Gonzalez-Carrasco E, Calvo C, et al. Hospital admission due to respiratory viral infections in moderate preterm, late preterm and term infants during their first year of life. Allergol Immunopathol (Madr). 2015;43(5):469–473.
  • Mauskopf J, Margulis AV, Samuel M, et al. Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: systematic Review. Pediatr Infect Dis J. 2016;35(7):e229–e38.
  • Straňák Z, Saliba E, Kosma P, et al. Predictors of RSV LRTI hospitalization in infants born at 33 to 35 weeks gestational age: a Large Multinational Study (PONI). PLoS One. 2016;11(6):e0157446.
  • Stephens AS, Lain SJ, Roberts CL, et al. Survival, hospitalization, and acute-care costs of very and moderate preterm infants in the first 6 years of life: a population based study. J Pediatr. 2016;169:61– 8.e3.
  • Elder DE, Hagan R, Evans SF, et al. Hospital admissions in the first year of life in very preterm infants. J Paediatr Child Health. 1999;35(2):145–150.
  • Greenough A, Cox S, Alexander J, et al. Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child. 2001;85(6):463–468.
  • Hong T, Bolisetty S, Bajuk B, et al. A population study of respiratory rehospitalisation in very preterm infants in the first 3 years of life. J Paediatr Child Health. 2016;52(7):7–21.
  • Resch B, Pasnocht A, Gusenleitner W, et al. Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age. J Infect. 2005;50(5):397–403.
  • Drysdale SB, Prendergast M, Alcazar M, et al. Genetic predisposition of RSV infection-related respiratory morbidity in preterm infants. Eur J Pediatr. 2014;173(7):905–912.
  • Awomoyi AA, Rallabhandi P, Pollin TI, et al. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol (Baltimore, Md: 1950). 2007;179(5):3171–3177.
  • Broughton S, Bhat R, Roberts A, et al. Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants. Arch Dis Child. 2006; 91(1):26–30.
  • Chawes BLK, Poorisrisak P, Johnston SL, et al. Neonatal bronchial hyperresponsiveness precedes acute severe viral bronchiolitis in infants. J Allergy Clin Immunol. 2012;130(2):354–61.e3.
  • Drysdale SB, Wilson T, Alcazar M, et al. Lung function prior to viral lower respiratory tract infections in pre-maturely born infants. Thorax. 2011;66(6):468–473.
  • Glezen WP, Taber LH, Frank AL, et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Children. 1986;140(6):543–546.
  • Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. New England J Med. 2009;360(6):588–598.
  • Stein RT, Bont LJ, Zar H, et al. Respiratory syncytial virus hospitalization and mortality: systematic review and meta-analysis. Pediatr Pulmonol. 2017;52(4):556–569.
  • Gouyon J-B, Roze J-C, Guillermet-Fromentin C, et al. Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at < 33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study. Epidemiol Infect. 2013;141(04):816–826.
  • Carbonell-Estrany X, Quero J, Group IS. Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons. Pediatr Infect Dis J. 2001;20(9):874–879.
  • Resch B, Kurath S, Manzoni P. Epidemiology of respiratory syncytial virus infection in preterm infants. Open Microbiol J. 2011;5:135–143.
  • Liese JG, Grill E, Fischer B, et al. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr. 2003;162(4):230–236.
  • Ricart S, Marcos MA, Sarda M, et al. Clinical risk factors are more relevant than respiratory viruses in predicting bronchiolitis severity. Pediatr Pulmonol. 2013;48(5):456–463.
  • Resch B, Paes B. Are late preterm infants as susceptible to RSV infection as full term infants? Early Hum Dev. 2011;87 Suppl 1:S47–49.
  • Steen O, Miri F, Gunjaca M, et al. The burden of severe respiratory syncytial virus disease among children younger than 1 year in Central and Eastern Europe. Infect Dis Ther. 2016;1–13.
  • Drysdale SB, Alcazar-Paris M, Wilson T, et al. Viral lower respiratory tract infections and preterminfants’ healthcare utilisation. Eur J Pediatr. 2015;174(2):209–215.
  • Greenough A, Alexander J, Boit P, et al. School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants. Thorax. 2009;64(6):490–495.
  • Sampalis JS. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J Pediatr. 2003;143(5 Suppl):S150–S156.
  • Montgomery S, Bahmanyar S, Brus O, et al. Respiratory infections in preterm infants and subsequent asthma: a cohort study. BMJ Open. 2013;3(10):e004034.
  • Fauroux B, Gouyon JB, Roze JC, et al. Respiratory morbidity of preterm infants of less than 33 weeks gestation without bronchopulmonary dysplasia: a 12-month follow-up of the CASTOR study cohort. Epidemiol Infect. 2014;142(7):1362–1374.
  • Romero JR, Stewart DL, Buysman EK, et al. Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants. Clin Ther. 2010;32(14):2422–2432.
  • Greenough A, Broughton S. Chronic manifestations of respiratory syncytial virus infection in premature infants. Pediatr Infect Dis J. 2005; 24(11Suppl): p. S184-7, discussion S187-8.
  • Drysdale SB, Lo J, Prendergast M, et al. Lung function of preterm infants before and after viral infections. Eur J Pediatr. 2014;173(11):1497–1504.
  • Broughton S, Sylvester KP, Fox G, et al. Lung function in prematurely born infants after viral lower respiratory tract infections. Pediatr Infect Dis J. 2007;26 (11):1019–1024.
  • Feldman AS, He Y, Moore ML, et al. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Am J Respir Crit Care Med. 2015;191(1):34–44.
  • Benoit LA, Holtzman MJ. New immune pathways from chronic post-viral lung disease. Ann N Y Acad Sci. 2010;1183:195–210.
  • Estripeaut D, Torres JP, Somers CS, et al. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J Infect Dis. 2008;198(10):1435–1443.
  • Chavez-Bueno S, Mejias A, Gomez AM, et al. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol J. 2005;2:46.
  • Schuurhof A, Janssen R, de Groot H, et al. Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze. Respir Res. 2011;12:121.
  • Loebbermann J, Schnoeller C, Thornton H, et al. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS One. 2012;7(2):e32371.
  • Bont L, Heijnen CJ, Kavelaars A, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one- year follow-up study. Am J Respir Crit Care Med. 2000;161(5):1518–1523.
  • Schwarze J, O’Donnell DR, Rohwedder A, et al. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med. 2004;169(7):801–805.
  • Romero JR. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Pediatr Infect Dis J. 2003;22(2Suppl):S46–S54.
  • Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. New England J Med. 2013;368(19):1791–1799.
  • Simoes EA, Carbonell-Estrany X, Rieger CH, et al. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol. 2010;126(2):256–262.
  • Brady MT, Byington CL, Davies HD, et al. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014. 134(2): e620–e638.
  • Farber HJ, Buckwold FJ, Lachman B, et al. Observed effectiveness of Palivizumab for 29–36-week gestation infants. Pediatrics. 2016;138:e20160627.
  • Mochizuki H, Kusuda S, Okada K, et al. Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing. Six-year follow-up study. Am J Respir Crit Care Med. 2017;196(1):29–38.
  • Wang D, Cummins C, Bayliss S, et al. Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation. Health Technol Assess (Rockv). 2008; 12(36):iii–86.
  • Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, anagement, and prevention of bronchiolitis. Pediatrics. 2014;134(5): e1474–e502.
  • Mazur NI, Martinon-Torres F, Baraldi E, et al. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Resp Med. 2015;3(11):888–900.
  • Kusel MM, de Klerk NH, Holt PG, et al. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J. 2006;25(8):680–686.
  • Jartti T, Lee W-M, Pappas T, et al. Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J. 2008;32(2):314–320.
  • Miller EK, Lu X, Erdman DD, et al. Rhinovirus-associated hospitalizations in young children. J Infect Dis. 2007;195(6):773–781.
  • Drysdale SB, Alcazar-Paris M, Wilson T, et al. Rhinovirus infection and healthcare utilisation in prematurely born infants. Eur Respir J. 2013;42(4):1029–1036.
  • Costa LF, Dao Q, da Silveira HL, et al. Human rhinovirus and disease severity in children. Pediatrics. 2014;133(2):e312–e21.
  • van Piggelen RO, van Loon AM, Krediet TG, et al. Human rhinovirus causes severe infection in preterm infants. Pediatr Infect Dis J. 2010;29(4):364–365.
  • Garbino J, Gerbase MW, Wunderli W, et al. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med. 2004;170(11):1197–1203.
  • Arden KE, McErlean P, Nissen MD, et al. Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J Med Virol. 2006;78(9):1232–1240.
  • Miller EK, Bugna J, Libster R, et al. Human rhinoviruses in severe respiratory disease in very low birth weight infants. Pediatrics. 2012;129(1):e60–e7.
  • Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, et al. Rhinovirus-induced wheezing in infancy–the first sign of childhood asthma? J Allergy Clin Immunol. 2003;111(1):66–71.
  • Lemanske RF Jr., Jackson DJ, Gangnon RE, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116(3):571–577.
  • Guilbert TW, Singh AM, Danov Z, et al. Decreased lung function after preschool wheezing rhinovirus illnesses in children at risk to develop asthma. J Allergy Clin Immunol. 2011; 128(3):532–8.e1–10.
  • Lemanske RF Jr. The childhood origins of asthma (COAST) study. Pediatr Allergy Immunol: off Publ Eur Soc Pediatr Allergy Immunol. 2002;13(Suppl 15):38–43.
  • Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178(7):667–672.
  • Midulla F, Pierangeli A, Cangiano G, et al. Rhinovirus bronchiolitis and recurrent wheezing: 1-year followup. Eur Respir J. 2012;39(2):396–402.
  • Cox DW, Bizzintino J, Ferrari G, et al. Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions. Am J Respir Crit Care Med. 2013;188(11):1358–1364.
  • Hong JY, Bentley JK, Chung Y, et al. Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. J Allergy Clin Immunol. 2014;134(2):429–39. e8.
  • Perez GF, Pancham K, Huseni S, et al. Rhino virus induced airway cytokines and respiratory morbidity in severely premature children. Pediatr Allergy Immunol: off Publ Eur Soc Pediatr Allergy Immunol. 2015;26(2):145–152.
  • Papadopoulos NG, Papi A, Psarras S, et al. Mechanisms of rhinovirus-induced asthma. Paediatr Respir Rev. 2004;5(3):255–260.
  • Perez GF, Jain A, Kurdi B, et al. Age-related effect of viral-induced wheezing in severe prematurity. Children. 2016; 3(4):19.
  • Megalaa R, Huseni S, Pancham K, et al. Premature Infants have an Intrinsic Airway Secretory Signature Characterized By Enhanced Production Of Airway Remodeling Growth Factors. B98 SIGNALING, REMODELING AND CONTRACTION IN THE AIRWAY. Am Thorac Soc. 2016; A4313–A.
  • Kusel MM, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119(5):1105–1110.
  • Baraldi E, Bonetto G, Zacchello F, et al. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation. Am J Respir Crit Care Med. 2005;171(1):68–72.
  • Halvorsen T, Skadberg BT, Eide GE, et al. Characteristics of asthma and airway hyper-responsiveness after premature birth. Pediatr Allergy Immunol. 2005;16(6):487–494.
  • Siltanen M1, Wehkalampi K, Hovi P, et al. Preterm birth reduces the incidence of atopy in adulthood. J Allergy Clin Immunol. 2011;127(4): 935–942.
  • Kwinta P, Lis G, Klimek M, et al. The prevalence and risk factors of allergic and respiratory symptoms in a regional cohort of extremely low birth weight children (<1000 g). Italian Journal of Pediatrics. 2013;39:4.
  • Mai XM, Gaddlin PO, Nilsson L, et al. Asthma, lung function and allergy in 12-year-old children with very low birth weight: a prospective study. Pediatr Allergy Immunol. 2003;14(3):184–192.
  • Siltanen M, Savilahti E, Pohjavuori M, et al. Respiratory symptoms and lung function in relation to atopy in children born preterm. Pediatr Pulmonol. 2004; 37(1):43–49.
  • Thompson WW, Shay DK, Weintraub E, et al. INfluenza-associated hospitalizations in the USA. JAMA. 2004;292(11):1333–1340.
  • Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40.
  • Iskander M, Booy R, Lambert S. The burden of influenza in children. Curr Opin Infect Dis. 2007;20(3):259–263.
  • Silvennoinen H, Peltola V, Vainionpaa R, et al. Incidence of influenza-related hospitalizations in different age groups of children in Finland: a 16-year study. Pediatr Infect Dis J. 2011;30(2):e24–e8.
  • Poehling KA, Edwards KM, Griffin MR, et al. The Burden of Influenza in Young Children, 2004–2009. Pediatrics. 2013;131(2):207.
  • van den Hoogen BG, De Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7(6):719–724.
  • Jartti T, van den Hoogen B, Garofalo RP, et al. Metapneumovirus and acute wheezing in children. Lancet. 2002;360(9343):1393–1394.
  • Williams JV, Tollefson SJ, Heymann PW, et al. Human metapneumovirus infection in children hospitalized for wheezing. J Allergy Clin Immunol. 2005;115 (6):1311–1312.
  • Garcia-Garcia ML, Calvo C, Perez-Brena P, et al. Prevalence and clinical characteristics of human metapneumovirus infections in hospitalized infants in Spain. Pediatr Pulmonol. 2006;41(9):863–871.
  • Edwards KM, Zhu Y, Griffin MR, et al. Burden of human metapneumovirus infection in young children. N Engl J Med. 2013;368(7):633–643.
  • Sami-Zakhari I, Perez GF, Huseni S, et al. Human Metapneumovirus is associated with severe respiratory disease in premature children. C51 PEDIATRIC RESPIRATORY INFECTIONS. Am Thorac Soc. 2014; A4683–A.
  • Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A. 2005;102 (36):12891–12896.
  • Jartti T, Hedman K, Jartti L, et al. Human bocavirus the first 5 years. Rev Med Virol. 2012;22(1):46–64.
  • Regamey N, Frey U, Deffernez C, et al. Isolation of human bocavirus from Swiss infants with respiratory infections. Pediatr Infect Dis J. 2007;26(2):177–179.
  • Schildgen O, Muller A, Allander T, et al. Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev. 2008;21(2):291–304. table of contents.
  • Garcia-Garcia ML, Calvo C, Falcon A, et al. Role of emerging respiratory viruses in children with severe acute wheezing. Pediatr Pulmonol. 2010;45(6):585–591.
  • Calvo C, García-García M, Blanco C, et al. Human bocavirus infection in a neonatal intensive care unit. J Infect. 2008;57(3):269–271.
  • Uršic T, Krivec U, Kalan G, et al. Fatal human bocavirus infection in an 18-month-old child with chronic lung disease of prematurity. Pediatr Infect Dis J. 2015;34(1):111–112.